Monday, March 05, 2007 12:23:48 AM
DNAG aside, (not to mention that DNAG came on board with Emory the moment the EPA for MK0518 became public, or the fact that in that 24 week period to date in Feb. "miraculous strides were made in the development of that compound) a cure for HIV has been found by Merck, at Emory:
In fact, most patients who had been treated on a variety of antiretroviral therapies who were given MK0518 - being developed by Merck - were able to suppress their bloodstream levels of virus to undetectable levels.
http://www.medpagetoday.com/InfectiousDisease/2006CROIMeeting/tb/2644
This is huge.
Can anybody on this board tell me if our technology participated in this? Can anybody tell me what other applications our technology at Emory could have been applied to?
Does anybody realize Wall Street has heard about this and is just waiting for validation to invest heavily in personalized medicine?
http://www.thestreet.com/markets/corrections/10337044.html
For the record, I own 1,377,222 shares of DNAG. Should I sell them and buy MRK?
FEATURED CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • Oct 8, 2024 8:00 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM